Table 1 Patient characteristics (n = 575).

From: Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT)

Characteristics

N (%)

Age

57 (20, 71)

Male

335 (62)

High riska

201 (35)

Induction

Lines, med (range)

1 (1, 3)

Triplets

427 (96)

Doublets

15 (3)

Missing

3 (1)

Treatment arm

Auto-maintenance

198 (34)

Auto-RVD

195 (34)

Auto-Auto

182 (32)

Reported diagnostic isotype, n (%)

GK/GL

224 (39)/103 (18)

AK/AL

45 (8)/39 (7)

Free K/free L

75 (13)/31 (5)

MK/ML

3 (<1)/0 (0)

DK/DL

1 (<1)/3 (<1)

≥Biclonal

15 (2)

Neg

1 (<1)

Missing

35 (6)

CTN response at entry

≥CR

96 (18)

VGPRb

169 (29)

PR

255 (44)

<PR or not evaluated

55 (9)

Positive Mass-Fix at enrollment

437 (76)

  1. aHigh risk was defined as beta-2 microglobulin >5 mg/L or presence of t(4;14), t(14:16), t(14;20), deletion 17p, aneuploidy by FISH or metaphase cytogenetics or deletion 13q by metaphase cytogenetics.
  2. bIncludes nCR and VGPR.
Back to article page